These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 20819899)

  • 41. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants.
    Warmerdam LA; van Wezel-Meijler G; de Vries LS; Groenendaal F; Steggerda SJ
    Neonatology; 2023; 120(5):615-623. PubMed ID: 37379806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits.
    Cheong JLY; Doyle LW
    Semin Fetal Neonatal Med; 2019 Jun; 24(3):197-201. PubMed ID: 30962159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.
    Skinner AM; Battin M; Solimano A; Daaboul J; Kitson HF
    Am J Perinatol; 1997 Oct; 14(9):539-46. PubMed ID: 9394163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.
    Cole CH; Colton T; Shah BL; Abbasi S; MacKinnon BL; Demissie S; Frantz ID
    N Engl J Med; 1999 Apr; 340(13):1005-10. PubMed ID: 10099142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Perinatal glucocorticosteroid therapy: time for reconsideration].
    Groneck P
    Z Geburtshilfe Neonatol; 2001; 205(6):231-5. PubMed ID: 11745009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurological adverse effects of early postnatal dexamethasone in very preterm infants.
    Baud O; Zupan V; Lacaze-Masmonteil T; Dehan M
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F159. PubMed ID: 10325800
    [No Abstract]   [Full Text] [Related]  

  • 48. Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy.
    Powell K; Kerkering KW; Barker G; Rozycki HJ
    J Matern Fetal Neonatal Med; 2006 Jan; 19(1):43-8. PubMed ID: 16492591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postnatal Corticosteroids to Prevent or Treat Chronic Lung Disease Following Preterm Birth.
    Cummings JJ; Pramanik AK;
    Pediatrics; 2022 Jun; 149(6):. PubMed ID: 37917016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(2):111-7. PubMed ID: 20150750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of dexamethasone and spironolactone therapy on diuresis and creatine clearance in premature infants with a birth weight below 1,500 g].
    Sonntag J
    Klin Padiatr; 1996; 208(6):319-22. PubMed ID: 9064372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
    Smith LM; Qureshi N; Chao CR
    J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-inflammatory therapy in the neonatal intensive care unit: present and future.
    Watterberg K
    Semin Fetal Neonatal Med; 2006 Oct; 11(5):378-84. PubMed ID: 16632414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. More trials on early treatment with corticosteroids are needed.
    Subhedar NV; Bennett AJ; Wardle SP; Shaw NJ
    BMJ; 2000 Apr; 320(7239):941. PubMed ID: 10742018
    [No Abstract]   [Full Text] [Related]  

  • 55. Medical complications in premature infants: is treatment enough?
    Stahlman MT
    N Engl J Med; 1989 Jun; 320(23):1551-3. PubMed ID: 2725585
    [No Abstract]   [Full Text] [Related]  

  • 56. Using dexamethasone to treat bronchopulmonary dysplasia.
    Van Ekeren RF
    Neonatal Netw; 1991 Oct; 10(3):17-21. PubMed ID: 1944082
    [No Abstract]   [Full Text] [Related]  

  • 57. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
    Merz U; Pfäffle R; Peschgens T; Hörnchen H
    Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
    Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
    Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
    Onland W; Offringa M; De Jaegere AP; van Kaam AH
    Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis.
    Zeng L; Tian J; Song F; Li W; Jiang L; Gui G; Zhang Y; Ge L; Shi J; Sun X; Mu D; Zhang L
    Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F506-F511. PubMed ID: 29475879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.